Cover Image
市場調查報告書

Collegium Pharmaceutical, Inc.:產品平台分析

Collegium Pharmaceutical, Inc. - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 224674
出版日期 內容資訊 英文 32 Pages
訂單完成後即時交付
價格
Back to Top
Collegium Pharmaceutical, Inc.:產品平台分析 Collegium Pharmaceutical, Inc. - Product Pipeline Review - 2015
出版日期: 2015年07月31日 內容資訊: 英文 32 Pages
簡介

Collegium Pharmaceutical, Inc.是開發後期階段醫藥品的製藥公司。致力於開發受專利保護的獨家、附防仿冒功能、採用緩釋長效型藥物遞送平台之慢性疼痛治療藥。

本報告提供Collegium Pharmaceutical, Inc.的治療藥開發平台現況及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

Collegium Pharmaceutical, Inc.的基本資料

  • Collegium Pharmaceutical, Inc.概要
  • 主要資訊
  • 企業資料

Collegium Pharmaceutical, Inc.:R&D概要

  • 主要的治療範圍

Collegium Pharmaceutical, Inc.:開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品

Collegium Pharmaceutical, Inc.:開發中產品概況

  • 最後階段的開發中產品
    • 登記前的產品/聯合治療模式
  • 初期階段的開發中產品
  • IND/CTA 所申請的產品/聯合治療模式
    • 前臨床階段的產品/聯合治療模式

Collegium Pharmaceutical, Inc.:藥物簡介

  • oxycodone hydrochloride ER
  • oxymorphone hydrochloride ER
  • hydrocodone bitartrate
  • hydrocodone bitartrate ER
  • methylphenidate
  • morphine sulfate

Collegium Pharmaceutical, Inc.:開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

Collegium Pharmaceutical, Inc.:最近的開發平台趨勢

Collegium Pharmaceutical, Inc.:暫停中的計劃

Collegium Pharmaceutical, Inc.:總公司和子公司的所在地

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07211CDB

Summary

Global Markets Direct's, 'Collegium Pharmaceutical, Inc. - Product Pipeline Review - 2015', provides an overview of the Collegium Pharmaceutical, Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Collegium Pharmaceutical, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Collegium Pharmaceutical, Inc. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Collegium Pharmaceutical, Inc.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Collegium Pharmaceutical, Inc.'s pipeline products

Reasons to buy

  • Evaluate Collegium Pharmaceutical, Inc.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Collegium Pharmaceutical, Inc. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Collegium Pharmaceutical, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Collegium Pharmaceutical, Inc. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Collegium Pharmaceutical, Inc.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Collegium Pharmaceutical, Inc. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Collegium Pharmaceutical, Inc. Snapshot
    • Collegium Pharmaceutical, Inc. Overview
    • Key Information
    • Key Facts
  • Collegium Pharmaceutical, Inc. - Research and Development Overview
    • Key Therapeutic Areas
  • Collegium Pharmaceutical, Inc. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Collegium Pharmaceutical, Inc. - Pipeline Products Glance
    • Collegium Pharmaceutical, Inc. - Late Stage Pipeline Products
      • Pre-Registration Products/Combination Treatment Modalities
    • Collegium Pharmaceutical, Inc. - Early Stage Pipeline Products
      • IND/CTA Filed Products/Combination Treatment Modalities
      • Preclinical Products/Combination Treatment Modalities
  • Collegium Pharmaceutical, Inc. - Drug Profiles
    • oxycodone hydrochloride ER
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • oxymorphone hydrochloride ER
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • hydrocodone bitartrate
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • hydrocodone bitartrate ER
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • methylphenidate
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • morphine sulfate
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Collegium Pharmaceutical, Inc. - Pipeline Analysis
    • Collegium Pharmaceutical, Inc. - Pipeline Products by Target
    • Collegium Pharmaceutical, Inc. - Pipeline Products by Route of Administration
    • Collegium Pharmaceutical, Inc. - Pipeline Products by Molecule Type
    • Collegium Pharmaceutical, Inc. - Pipeline Products by Mechanism of Action
  • Collegium Pharmaceutical, Inc. - Recent Pipeline Updates
  • Collegium Pharmaceutical, Inc. - Dormant Projects
  • Collegium Pharmaceutical, Inc. - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Collegium Pharmaceutical, Inc., Key Information
  • Collegium Pharmaceutical, Inc., Key Facts
  • Collegium Pharmaceutical, Inc. - Pipeline by Indication, 2015
  • Collegium Pharmaceutical, Inc. - Pipeline by Stage of Development, 2015
  • Collegium Pharmaceutical, Inc. - Monotherapy Products in Pipeline, 2015
  • Collegium Pharmaceutical, Inc. - Pre-Registration, 2015
  • Collegium Pharmaceutical, Inc. - IND/CTA Filed, 2015
  • Collegium Pharmaceutical, Inc. - Preclinical, 2015
  • Collegium Pharmaceutical, Inc. - Pipeline by Target, 2015
  • Collegium Pharmaceutical, Inc. - Pipeline by Route of Administration, 2015
  • Collegium Pharmaceutical, Inc. - Pipeline by Molecule Type, 2015
  • Collegium Pharmaceutical, Inc. - Pipeline Products by Mechanism of Action, 2015
  • Collegium Pharmaceutical, Inc. - Recent Pipeline Updates, 2015
  • Collegium Pharmaceutical, Inc. - Dormant Developmental Projects,2015
  • Collegium Pharmaceutical, Inc., Subsidiaries

List of Figures

  • Collegium Pharmaceutical, Inc. - Pipeline by Top 10 Indication, 2015
  • Collegium Pharmaceutical, Inc. - Pipeline by Stage of Development, 2015
  • Collegium Pharmaceutical, Inc. - Monotherapy Products in Pipeline, 2015
  • Collegium Pharmaceutical, Inc. - Pipeline by Top 10 Target, 2015
  • Collegium Pharmaceutical, Inc. - Pipeline by Top 10 Route of Administration, 2015
  • Collegium Pharmaceutical, Inc. - Pipeline by Top 10 Molecule Type, 2015
  • Collegium Pharmaceutical, Inc. - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top